Cover Image
市場調查報告書

Aslan Pharmaceuticals Pte. Ltd. - 產品平台分析

Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 257888
出版日期 內容資訊 英文 30 Pages
訂單完成後即時交付
價格
Back to Top
Aslan Pharmaceuticals Pte. Ltd. - 產品平台分析 Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2015
出版日期: 2015年10月14日 內容資訊: 英文 30 Pages
簡介

Aslan Pharmaceuticals Pte. Ltd. 是在各種治療領域製造、銷售劃時代治療藥的製藥公司。特別致力於固態腫瘤和類風濕性關節炎的治療藥的開發,主要發展地區為亞太地區。

本報告提供Aslan Pharmaceuticals Pte. Ltd.的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Aslan Pharmaceuticals Pte. Ltd.的基本資料

Aslan Pharmaceuticals Pte. Ltd.概要

  • 主要資訊
  • 企業資料

Aslan Pharmaceuticals Pte. Ltd.:R&D概要

  • 主要的治療範圍

Aslan Pharmaceuticals Pte. Ltd.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

Aslan Pharmaceuticals Pte. Ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

Aslan Pharmaceuticals Pte. Ltd.:藥物簡介

  • varlitinib
  • ASLAN-003
  • BMS-777607
  • ASLAN-004

Aslan Pharmaceuticals Pte. Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Aslan Pharmaceuticals Pte. Ltd.:最近的開發平台趨勢

Aslan Pharmaceuticals Pte. Ltd.:暫停中的計劃

Aslan Pharmaceuticals Pte. Ltd.:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07667CDB

Summary

Global Markets Direct's, 'Aslan Pharmaceuticals Pte. Ltd. - Product Pipeline Review - 2015', provides an overview of the Aslan Pharmaceuticals Pte. Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Aslan Pharmaceuticals Pte. Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Aslan Pharmaceuticals Pte. Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Aslan Pharmaceuticals Pte. Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Aslan Pharmaceuticals Pte. Ltd.'s pipeline products

Reasons to buy

  • Evaluate Aslan Pharmaceuticals Pte. Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Aslan Pharmaceuticals Pte. Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Aslan Pharmaceuticals Pte. Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Aslan Pharmaceuticals Pte. Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aslan Pharmaceuticals Pte. Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Aslan Pharmaceuticals Pte. Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Aslan Pharmaceuticals Pte. Ltd. Snapshot
    • Aslan Pharmaceuticals Pte. Ltd. Overview
    • Key Information
    • Key Facts
  • Aslan Pharmaceuticals Pte. Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products Glance
    • Aslan Pharmaceuticals Pte. Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Aslan Pharmaceuticals Pte. Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Aslan Pharmaceuticals Pte. Ltd. - Drug Profiles
    • varlitinib
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ASLAN-003
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BMS-777607
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ASLAN-004
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline Analysis
    • Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Target
    • Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Route of Administration
    • Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Molecule Type
    • Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Mechanism of Action
  • Aslan Pharmaceuticals Pte. Ltd. - Recent Pipeline Updates
  • Aslan Pharmaceuticals Pte. Ltd. - Dormant Projects
  • Aslan Pharmaceuticals Pte. Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Aslan Pharmaceuticals Pte. Ltd., Key Information
  • Aslan Pharmaceuticals Pte. Ltd., Key Facts
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Indication, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Stage of Development, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Monotherapy Products in Pipeline, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Partnered Products in Pipeline, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Partnered Products/ Combination Treatment Modalities, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Phase II, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Phase I, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Preclinical, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Target, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Route of Administration, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Molecule Type, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Recent Pipeline Updates, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Dormant Developmental Projects,2015
  • Aslan Pharmaceuticals Pte. Ltd., Other Locations

List of Figures

  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Top 10 Indication, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Stage of Development, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Monotherapy Products in Pipeline, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Top 10 Target, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Aslan Pharmaceuticals Pte. Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top